CN103127020A - 阿法骨化醇缓释制剂及其制备方法 - Google Patents
阿法骨化醇缓释制剂及其制备方法 Download PDFInfo
- Publication number
- CN103127020A CN103127020A CN2013100529557A CN201310052955A CN103127020A CN 103127020 A CN103127020 A CN 103127020A CN 2013100529557 A CN2013100529557 A CN 2013100529557A CN 201310052955 A CN201310052955 A CN 201310052955A CN 103127020 A CN103127020 A CN 103127020A
- Authority
- CN
- China
- Prior art keywords
- alfacalcidol
- slow releasing
- preparation
- releasing preparation
- sustained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
1小时 | 4小时 | 8小时 | 12小时 | 16小时 | 20小时 | 24小时 | |
实施例1 | 34% | 56% | 78% | 100% | |||
实施例2 | 31% | 53% | 76% | 101.2% | |||
实施例3 | 26% | 45% | 67% | 87% | 100% | ||
实施例4 | 20% | 42% | 63% | 81% | 92% | 101.1% | |
实施例5 | 11% | 27% | 38% | 54% | 71% | 86% | 100.1% |
实施例6 | 23% | 37% | 58% | 79% | 90% | 100.2% | |
实施例7 | 25% | 40% | 61% | 82% | 93% | 100% | |
实施例8 | 27% | 42% | 64% | 83% | 94% | 100.2 | |
实施例9 | 28% | 48% | 69% | 89% | 95% | 100.1 | |
实施例10 | 24% | 46% | 65% | 86% | 94.5% | 100.1 | |
实施例11 | 21% | 43% | 62% | 84% | 93.5% | 100 | |
实施例12 | 26% | 44% | 66% | 85% | 92.5% | 100.2 | |
实施例13 | 29% | 51% | 72% | 91% | 100.1 | ||
实施例14 | 22% | 46% | 68% | 85.8% | 93.2% | 100.1 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310052955.7A CN103127020B (zh) | 2013-02-19 | 2013-02-19 | 阿法骨化醇缓释制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310052955.7A CN103127020B (zh) | 2013-02-19 | 2013-02-19 | 阿法骨化醇缓释制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103127020A true CN103127020A (zh) | 2013-06-05 |
CN103127020B CN103127020B (zh) | 2014-07-23 |
Family
ID=48487897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310052955.7A Active CN103127020B (zh) | 2013-02-19 | 2013-02-19 | 阿法骨化醇缓释制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103127020B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104739793A (zh) * | 2015-04-22 | 2015-07-01 | 青岛正大海尔制药有限公司 | 一种阿法骨化醇片及其制备方法 |
CN104800185A (zh) * | 2015-04-22 | 2015-07-29 | 青岛正大海尔制药有限公司 | 阿法骨化醇缓释片及其制备方法 |
JP2020534365A (ja) * | 2018-05-09 | 2020-11-26 | 南京海融医薬科技股▲フン▼有限公司 | ビタミンdアナログ製剤およびその調製方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1579410A (zh) * | 2003-07-31 | 2005-02-16 | 安徽省药物研究所 | 口服三七总皂苷调释制剂 |
US20050209203A1 (en) * | 2003-07-30 | 2005-09-22 | Jin Tian | Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease |
CN103099796A (zh) * | 2013-02-19 | 2013-05-15 | 青岛正大海尔制药有限公司 | 含有苷糖酯的缓释制剂及其制备方法 |
CN103110631A (zh) * | 2013-02-19 | 2013-05-22 | 青岛正大海尔制药有限公司 | 复方酚美麻敏缓释制剂及其制备方法 |
CN103110638A (zh) * | 2013-02-19 | 2013-05-22 | 青岛正大海尔制药有限公司 | 酚咖缓释制剂及其制备方法 |
-
2013
- 2013-02-19 CN CN201310052955.7A patent/CN103127020B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050209203A1 (en) * | 2003-07-30 | 2005-09-22 | Jin Tian | Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease |
CN1579410A (zh) * | 2003-07-31 | 2005-02-16 | 安徽省药物研究所 | 口服三七总皂苷调释制剂 |
CN103099796A (zh) * | 2013-02-19 | 2013-05-15 | 青岛正大海尔制药有限公司 | 含有苷糖酯的缓释制剂及其制备方法 |
CN103110631A (zh) * | 2013-02-19 | 2013-05-22 | 青岛正大海尔制药有限公司 | 复方酚美麻敏缓释制剂及其制备方法 |
CN103110638A (zh) * | 2013-02-19 | 2013-05-22 | 青岛正大海尔制药有限公司 | 酚咖缓释制剂及其制备方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104739793A (zh) * | 2015-04-22 | 2015-07-01 | 青岛正大海尔制药有限公司 | 一种阿法骨化醇片及其制备方法 |
CN104800185A (zh) * | 2015-04-22 | 2015-07-29 | 青岛正大海尔制药有限公司 | 阿法骨化醇缓释片及其制备方法 |
CN104800185B (zh) * | 2015-04-22 | 2018-03-09 | 青岛正大海尔制药有限公司 | 阿法骨化醇缓释片及其制备方法 |
CN104739793B (zh) * | 2015-04-22 | 2018-03-09 | 青岛正大海尔制药有限公司 | 一种阿法骨化醇片及其制备方法 |
JP2020534365A (ja) * | 2018-05-09 | 2020-11-26 | 南京海融医薬科技股▲フン▼有限公司 | ビタミンdアナログ製剤およびその調製方法 |
JP7062246B2 (ja) | 2018-05-09 | 2022-05-06 | 南京海融医薬科技股▲フン▼有限公司 | ビタミンdアナログ製剤およびその調製方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103127020B (zh) | 2014-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100159001A1 (en) | Extended-Release Pharmaceutical Formulations | |
BR112014024964A2 (pt) | formulação compósita compreendendo comprimido esferoidal de multi-unidade (must) encapsulado em cápsula dura e método para sua preparação | |
CN103127020B (zh) | 阿法骨化醇缓释制剂及其制备方法 | |
CN104661649A (zh) | 包含替格瑞洛的固态口服医药制剂 | |
US10258562B2 (en) | Effervescent tablet containing high level of aspirin | |
US20160106766A1 (en) | Solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d | |
CN103655505B (zh) | 一种止痛类双层控释片及其制备方法 | |
CN103110606B (zh) | 阿法骨化醇胶囊及其制备方法 | |
KR20080110615A (ko) | 서방성 정제의 제조 방법 | |
CN103908434A (zh) | 一种枸橼酸西地那非片 | |
CN103110638B (zh) | 酚咖缓释制剂及其制备方法 | |
CN103099796B (zh) | 含有甘糖酯的缓释制剂及其制备方法 | |
CN103127015B (zh) | 阿法骨化醇滴丸及其制备方法 | |
CN102058517A (zh) | 一种帕潘立酮缓释剂及其制备方法 | |
CN103110631B (zh) | 复方酚美麻敏缓释制剂及其制备方法 | |
CN103142623B (zh) | 骨化三醇和雷尼酸锶的混悬颗粒及其制备方法 | |
CN103690505A (zh) | 一种安眠类双层控释片及其制备方法 | |
CN104739793B (zh) | 一种阿法骨化醇片及其制备方法 | |
CN100441201C (zh) | 含积雪草水溶性有效组分的中药缓释制剂及其制备方法 | |
EP2591768B1 (en) | Single unit dosage formulations of sevelamer and fat soluble vitamins and surface active agents | |
CN104887639B (zh) | 盐酸曲美他嗪单层渗透泵控释片及制备方法 | |
CN105534929A (zh) | 曲格列汀药物组合物 | |
CN103948552A (zh) | 一种奥卡西平控释片及其制备方法 | |
CN102784116A (zh) | 一种高溶出度非诺贝特分散片及其制备方法 | |
CN103142553A (zh) | 一种骨化三醇缓释胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 266103 Qingdao economic and Technological Development Zone, unity Road, No. 3601, Shandong Applicant after: Qingdao Zhengda Haier Pharmaceutical Co., Ltd. Address before: 266103 Haier Road, Shandong, Qingdao, No. 1 Applicant before: Qingdao Zhengda Haier Pharmaceutical Co., Ltd. |
|
CB02 | Change of applicant information | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 266103 3601 Tuen Jie Road, Qingdao economic and Technological Development Zone, Shandong Patentee after: Zhengda Pharmaceutical (Qingdao) Co., Ltd. Address before: 266103 3601 Tuen Jie Road, Qingdao economic and Technological Development Zone, Shandong Patentee before: Qingdao Zhengda Haier Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |